【24h】

Molecular genotyping of Indian blood group system antigens in Indian blood donors

机译:印度血液供体中印度血组系统抗原的分子基因分型

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundHaemagglutination has been the gold standard for defining the blood group status. However, these tests depend upon the availability of specific and reliable antisera. Potent antisera for extended phenotyping are very costly, weakly reacting or available in limited stocks and unavailable for some blood group systems like Indian, Dombrock, Coltan, Diego etc. The Indian blood group system consists of two antithetical antigens, Inaand Inb. The Ina/Inbpolymorphism arises from 252C?>?G missense mutation in the CD44 gene. This knowledge has allowed the development of molecular methods for genotyping IN alleles. Material and methodsBlood samples were collected from 715 blood donors from Mumbai. DNA was extracted using phenol-chloroform method and genotyping for Indian (Ina/IN*01, Inb/IN*02) blood group alleles was done by Sequence Specific PCR. ResultsSeventeen donors among 715 were heterozygous for Inaantigen i.e. In (a+b+). The Inaantigen positivity was confirmed serologically, using anti-Inaprepared in-house and the genotype-phenotype results were concordant. The frequency of Ina(2.37%) was higher than Caucasians and comparable to those reported among Indians of Bombay. ConclusionThis is the first study reporting molecular screening of Indian blood group antigens in Indian population. The frequency of Inaand Inbantigens was found to be 2.37% and 100% respectively. Red cells of Inapositive donors can be used as in-house reagent red cells for screening and identification of corresponding antibodies. Thus, DNA based methods will help in large scale screening of donors to identify rare blood groups, when commercial antisera are unavailable.
机译:Backgroundhaemagglutination一直是定义血型状态的金标准。然而,这些测试取决于特定和可靠的抗血清的可用性。延长表型的强化抗血清是非常昂贵的,在有限的股票中非常昂贵,弱效,并且对于印度,Dombrock,Coltan,Diego等一些血型系统而言,印度血型系统的血统系统也不可用。 Ina / inbolymorphism源于252℃?>?G致命突变在CD44基因中。这种知识使得在等位基因中的基因分型进行分子方法的发展。从孟买的715个献血者收集物质和方法。使用苯酚 - 氯仿方法和印度基因分型提取DNA(Ina / In * 01,Inb / In * 02)血型等位基因通过序列特异性PCR完成。在715中的结果venteen供体是Inaantigen的杂合子,I.在(A + B +)中。使用抗浸润的内部浸润性,基因型 - 表型结果进行了血清学阳性,并且基因型 - 表型结果得到了一致性的阳性。 INA的频率高于高加索人,并且与孟买印第安人报告的人相当。结论本届印度人群中印度血组抗原的第一研究报告。发现inaAsdInAntigens的频率分别为2.37%和100%。在内阳性供体的红细胞可用作内部试剂红细胞,用于筛选和鉴定相应的抗体。因此,当商业抗血清不可用时,基于DNA的方法将有助于识别稀有血液组的大规模筛选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号